Indications
prevention of venous thromboembolism
Composition
- Active substance
- semuloparin sodium
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Mulsevo
- Active substance
- semuloparin sodium
- Marketing authorisation holder
- Sanofi-aventis groupe
- Status
- Application withdrawn
- EMA product number
- EMEA/H/C/002516
EMA designations
- Orphan medicine
- No
- Conditional approval
- No
- Biosimilar
- No
- Generic
- No
- Accelerated assessment
- No
- Additional monitoring
- No
- Patient safety information
- No